Skip to main content
Have a personal or library account? Click to login
Oral Cancer Disparities in Low‑ and Middle‑Income Countries: A Global Health Equity Perspective on Prevention, Early Detection, and Treatment Access Cover

Oral Cancer Disparities in Low‑ and Middle‑Income Countries: A Global Health Equity Perspective on Prevention, Early Detection, and Treatment Access

Open Access
|Nov 2025

References

  1. Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209249. doi:10.3322/caac.21660.
  2. Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229263. doi:10.3322/caac.21834.
  3. Wu J, Chen H, Liu Y, Yang R, An N. The global, regional, and national burden of oral cancer, 1990–2021: A systematic analysis for the Global Burden of Disease Study 2021. J Cancer Res Clin Oncol. 2025;151(2):53. doi:10.1007/s00432-025-06098-w.
  4. Warnakulasuriya S, Kerr AR. Oral cancer screening: Past, present, and future. J Dent Res. 2021;100(12):13131320. doi:10.1177/00220345211014795.
  5. Gupta N, Gupta R, Acharya AK, et al. Changing trends in oral cancer—a global scenario. Nepal J Epidemiol. 2016;6(4):613619. doi:10.3126/nje.v6i4.17255.
  6. Shield KD, Ferlay J, Jemal A, et al. The global incidence of lip, oral cavity, and pharyngeal cancers by subsite in 2012. CA Cancer J Clin. 2017;67(1):5164. doi:10.3322/caac.21384.
  7. Ferlay J, Colombet M, Soerjomataram I, et al. Cancer statistics for the year 2020: An overview. Int J Cancer. 2021;149(4):778789. doi:10.1002/ijc.33588.
  8. Allemani C, Matsuda T, Di Carlo V, et al. Global surveillance of trends in cancer survival 2000‑14 (CONCORD‑3): Analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population‑based registries in 71 countries. Lancet. 2018;391(10125):10231075. doi:10.1016/S0140-6736(17)33326-3.
  9. Bray F, Parkin DM, African Cancer Registry Network. Cancer in sub‑Saharan Africa in 2020: A review of current estimates of the national burden, data gaps, and future needs. Lancet Oncol. 2022;23(6):719728. doi:10.1016/S1470-2045(22)00270-4.
  10. Ramos LF, Sobrinho AR, Ribeiro LN, et al. Racial disparity and prognosis in patients with mouth and oropharynx cancer in Brazil. Med Oral Patol Oral Cir Bucal. 2022;27(4):e392e396. doi:10.4317/medoral.25334.
  11. Johnson NW, Jayasekara P, Amarasinghe AA. Squamous cell carcinoma and precursor lesions of the oral cavity: Epidemiology and aetiology. Periodontol. 2000. 2011;57(1):1937. doi:10.1111/j.1600-0757.2011.00401.x.
  12. Knaul FM, Farmer PE, Krakauer EL, et al. Alleviating the access abyss in palliative care and pain relief—an imperative of universal health coverage: The Lancet Commission report. Lancet. 2018;391(10128):13911454. doi:10.1016/S0140-6736(17)32513-8.
  13. Petersen PE. The World Oral Health Report 2003: Continuous improvement of oral health in the 21st century—the approach of the WHO Global Oral Health Programme. Community Dent Oral Epidemiol. 2003;31(Suppl 1):323. doi:10.1046/j..2003.com122.x.
  14. Sankaranarayanan R, Ramadas K, Amarasinghe H, Subramanian S, Johnson N. Oral cancer: Prevention, early detection, and treatment. In: Gelband H, Jha P, Sankaranarayanan R, Horton S, eds. Cancer: Disease Control Priorities, Third Edition (Volume 3). The International Bank for Reconstruction and Development/The World Bank; 2015.
  15. Atun R, Jaffray DA, Barton MB, et al. Expanding global access to radiotherapy. Lancet Oncol. 2015;16(10):11531186. doi:10.1016/S1470-2045(15)00222-3.
  16. Farmer P, Frenk J, Knaul FM, et al. Expansion of cancer care and control in countries of low and middle income: A call to action. Lancet. 2010;376(9747):11861193. doi:10.1016/S0140-6736(10)61152-X.
  17. Sullivan R, Alatise OI, Anderson BO, et al. Global cancer surgery: Delivering safe, affordable, and timely cancer surgery. Lancet Oncol. 2015;16(11):11931224. doi:10.1016/S1470-2045(15)00223-5.
  18. Gupta B, Johnson NW. Emerging and established global life‑style risk factors for cancer of the upper aero‑digestive tract. Asian Pac J Cancer Prev. 2014;15(15):59835991. doi:10.7314/apjcp.2014.15.15.5983.
  19. Shankar A, Parascandola M, Sakthivel P, Kaur J, Saini D, Jayaraj NP. Advancing tobacco cessation in LMICs. Curr Oncol. 2022;29(12):91179124. doi:10.3390/curroncol29120713.
  20. Mehrtash H, Duncan K, Parascandola M, et al. Defining a global research and policy agenda for betel quid and areca nut. Lancet Oncol. 2017;18(12):e767e775. doi:10.1016/S1470-2045(17)30460-6.
  21. Itumalla R, Khatib MN, Gaidhane S, et al. Smokeless tobacco consumption among women of reproductive age: A systematic review and meta‑analysis. BMC Public Health. 2024;24(1):1361. doi:10.1186/s12889-024-18840-z.
  22. Bushi G, Khatib MN, Balaraman AK, et al. Prevalence of dual use of combustible tobacco and E‑cigarettes among pregnant smokers: A systematic review and meta‑analysis. BMC Public Health. 2024;24:3200. doi:10.1186/s12889-024-20746-9.
  23. Bagnardi V, Rota M, Botteri E, et al. Alcohol consumption and site‑specific cancer risk: A comprehensive dose‑response meta‑analysis. Br J Cancer. 2015;112(3):580593. doi:10.1038/bjc.2014.579.
  24. Hashibe M, Brennan P, Chuang SC, et al. Interaction between tobacco and alcohol use and the risk of head and neck cancer: Pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Cancer Epidemiol Biomarkers Prev. 2009;18(2):541550. doi:10.1158/1055-9965.EPI-08-0347.
  25. Room R, Babor T, Rehm J. Alcohol and public health. Lancet. 2005;365(9458):519530. doi:10.1016/S0140-6736(05)17870-2.
  26. Lim SS, Vos T, Flaxman AD, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990‑2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):22242260. doi:10.1016/S0140-6736(12)61766-8.
  27. Gordon SB, Bruce NG, Grigg J, et al. Respiratory risks from household air pollution in low and middle income countries. Lancet Respir Med. 2014;2(10):823860. doi:10.1016/S2213-2600(14)70168-7.
  28. Global Burden of Disease 2019 Cancer Collaboration, Kocarnik JM, Compton K, et al. Cancer incidence, mortality, years of life lost, years lived with disability, and disability‑adjusted life years for 29 cancer groups from 2010 to 2019: A systematic analysis for the global burden of disease study 2019. JAMA Oncol. 2022;8(3):420444. doi:10.1001/jamaoncol.2021.6987.
  29. Chowdhury R, Ramond A, O’Keeffe LM, et al. Environmental toxic metal contaminants and risk of cardiovascular disease: Systematic review and meta‑analysis. BMJ. 2018;362:k3310. doi:10.1136/bmj.k3310.
  30. Pavia M, Pileggi C, Nobile CG, Angelillo IF. Association between fruit and vegetable consumption and oral cancer: A meta‑analysis of observational studies. Am J Clin Nutr. 2006;83(5):11261134. doi:10.1093/ajcn/83.5.1126.
  31. Black RE, Victora CG, Walker SP, et al. Maternal and child undernutrition and overweight in low‑income and middle‑income countries. Lancet. 2013;382(9890):427451. doi:10.1016/S0140-6736(13)60937-X.
  32. Santarelli RL, Pierre F, Corpet DE. Processed meat and colorectal cancer: A review of epidemiologic and experimental evidence. Nutr Cancer. 2008;60(2):131144. doi:10.1080/01635580701684872.
  33. Liu Y, Wu F. Global burden of aflatoxin‑induced hepatocellular carcinoma: A risk assessment. Environ Health Perspect. 2010;118(6):818824. doi:10.1289/ehp.0901388.
  34. Crider K, Williams J, Qi YP, et al. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Cochrane Database Syst Rev. 2022;2(2022):CD014217. doi:10.1002/14651858.CD014217.
  35. Petersen PE, Bourgeois D, Ogawa H, Estupinan‑Day S, Ndiaye C. The global burden of oral diseases and risks to oral health. Bull World Health Organ. 2005;83(9):661669.
  36. Watt RG, Daly B, Allison P, et al. Ending the neglect of global oral health: Time for radical action. Lancet. 2019;394(10194):261272. doi:10.1016/S0140-6736(19)31133-X.
  37. Penchansky R, Thomas JW. The concept of access: Definition and relationship to consumer satisfaction. Med Care. 1981;19(2):127140. doi:10.1097/00005650-198102000-00001.
  38. Yip W, Hsiao WC. Non‑evidence‑based policy: How effective is China’s new cooperative medical scheme in reducing medical impoverishment? Soc Sci Med. 2009;68(2):201209. doi:10.1016/j.socscimed.2008.09.066.
  39. Ruhangaza D, Kennedy LS, Tsongalis GJ. Providing diagnostic pathology services in low and middle‑income countries. Hematol Oncol Clin North Am. 2024;38(1):209216. doi:10.1016/j.hoc.2023.05.015.
  40. Abdel‑Wahab M, Bourque JM, Pynda Y, et al. Status of radiotherapy resources in Africa: An international atomic energy agency analysis. Lancet Oncol. 2013;14(4):e168175. doi:10.1016/S1470-2045(12)70532-6.
  41. Smith SM, Eadara A, Parkash V. Addressing quality and safety in anatomic pathology in low‑ and middle‑income countries. Front Med (Lausanne). 2022;9:1060179. doi:10.3389/fmed.2022.1060179.
  42. Mars M, Scott RE. Global e‑health policy: A work in progress. Health Aff (Millwood). 2010;29(2):237243. doi:10.1377/hlthaff.2009.0945.
  43. Kruse CS, Karem P, Shifflett K, Vegi L, Ravi K, Brooks M. Evaluating barriers to adopting telemedicine worldwide: A systematic review. J Telemed Telecare. 2018;24(1):412. doi:10.1177/1357633X16674087.
  44. Freeman HP, Muth BJ, Kerner JF. Expanding access to cancer screening and clinical follow‑up among the medically underserved. Cancer Pract. 1995;3(1):1930.
  45. Tauras JA. Tobacco control in low‑income and middle‑income countries: Findings from WHO FCTC investment cases. Tob Control. 2024;33(Suppl 1):s1s2. doi:10.1136/tc-2024-058717.
  46. Chaloupka FJ, Yurekli A, Fong GT. Tobacco taxes as a tobacco control strategy. Tob Control. 2012;21(2):172180. doi:10.1136/tobaccocontrol-2011-050417.
  47. Callinan JE, Clarke A, Doherty K, Kelleher C. Legislative smoking bans for reducing secondhand smoke exposure, smoking prevalence and tobacco consumption. Cochrane Database Syst Rev. 2010;(4):CD005992. doi:10.1002/14651858.CD005992.pub2.
  48. Wakefield MA, Loken B, Hornik RC. Use of mass media campaigns to change health behaviour. Lancet. 2010;376(9748):12611271. doi:10.1016/S0140-6736(10)60809-4.
  49. Bruni L, Diaz M, Barrionuevo‑Rosas L, et al. Global estimates of human papillomavirus vaccination coverage by region and income level: A pooled analysis. Lancet Glob Health. 2016;4(7):e453e463. doi:10.1016/S2214-109X(16)30099-7.
  50. LaMontagne DS, Bloem PJN, Brotherton JML, Gallagher KE, Badiane O, Ndiaye C. Progress in HPV vaccination in low‑ and lower‑middle‑income countries. Int J Gynaecol Obstet. 2017;138(Suppl 1):714. doi:10.1002/ijgo.12186.
  51. Campos NG, Sharma M, Clark A, et al. The health and economic impact of scaling cervical cancer prevention in 50 low‑ and lower‑middle‑income countries. Int J Gynaecol Obstet. 2017;138(Suppl 1):4756. doi:10.1002/ijgo.12184.
  52. Boeing H, Bechthold A, Bub A, et al. Critical review: Vegetables and fruit in the prevention of chronic diseases. Eur J Nutr. 2012;51(6):637663. doi:10.1007/s00394-012-0380-y.
  53. Garewal HS, Schantz S. Emerging role of beta‑carotene and antioxidant nutrients in prevention of oral cancer. Arch Otolaryngol Head Neck Surg. 1995;121(2):141144. doi:10.1001/archotol.1995.01890020005002.
  54. Mitchell NJ, Bowers E, Hurburgh C, Wu F. Potential economic losses to the US corn industry from aflatoxin contamination. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2016;33(3):540550. doi:10.1080/19440049.2016.1138545.
  55. Sankaranarayanan R, Ramadas K, Thomas G, et al. Effect of screening on oral cancer mortality in Kerala, India: A cluster‑randomised controlled trial. Lancet. 2005;365(9475):19271933. doi:10.1016/S0140-6736(05)66658-5.
  56. Brocklehurst P, Kujan O, O’Malley LA, Ogden G, Shepherd S, Glenny AM. Screening programmes for the early detection and prevention of oral cancer. Cochrane Database Syst Rev. 2013;2013(11):CD004150. doi:10.1002/14651858.CD004150.
  57. Walsh T, Liu JL, Brocklehurst P, et al. Clinical assessment to screen for the detection of oral cavity cancer and potentially malignant disorders in apparently healthy adults. Cochrane Database Syst Rev. 2013;2013(11):CD010173. doi:10.1002/14651858.CD010173.pub2.
  58. Siddiqui AA, Abideen MZU, Abdullah M, et al. Investigating oral cancer awareness in outpatient settings: A hospital‑based study. Bangladesh J Med Sci. 2025;24(2):450456. doi:10.3329/bjms.v24i2.81712.
  59. Elmore JG, Armstrong K, Lehman CD, Fletcher SW. Screening for breast cancer. JAMA. 2005;293(10):1245256. doi:10.1001/jama.293.10.1245.
  60. Kujan O, Glenny AM, Duxbury J, Thakker N, Sloan P. Evaluation of screening strategies for improving oral cancer mortality: A Cochrane systematic review. J Dent Educ. 2005;69(2):255265.
DOI: https://doi.org/10.5334/aogh.5003 | Journal eISSN: 2214-9996
Language: English
Submitted on: Oct 11, 2025
Accepted on: Nov 3, 2025
Published on: Nov 28, 2025
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2025 Delfin Lovelina Francis, Saravanan Sampoornam Pape Reddy, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.